全文获取类型
收费全文 | 5283篇 |
免费 | 371篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 31篇 |
儿科学 | 160篇 |
妇产科学 | 98篇 |
基础医学 | 1034篇 |
口腔科学 | 65篇 |
临床医学 | 424篇 |
内科学 | 1071篇 |
皮肤病学 | 149篇 |
神经病学 | 548篇 |
特种医学 | 142篇 |
外科学 | 444篇 |
综合类 | 15篇 |
一般理论 | 1篇 |
预防医学 | 460篇 |
眼科学 | 82篇 |
药学 | 349篇 |
中国医学 | 4篇 |
肿瘤学 | 589篇 |
出版年
2023年 | 28篇 |
2022年 | 48篇 |
2021年 | 86篇 |
2020年 | 55篇 |
2019年 | 120篇 |
2018年 | 127篇 |
2017年 | 82篇 |
2016年 | 104篇 |
2015年 | 137篇 |
2014年 | 165篇 |
2013年 | 246篇 |
2012年 | 389篇 |
2011年 | 408篇 |
2010年 | 201篇 |
2009年 | 236篇 |
2008年 | 375篇 |
2007年 | 393篇 |
2006年 | 396篇 |
2005年 | 378篇 |
2004年 | 412篇 |
2003年 | 343篇 |
2002年 | 329篇 |
2001年 | 46篇 |
2000年 | 32篇 |
1999年 | 55篇 |
1998年 | 80篇 |
1997年 | 46篇 |
1996年 | 48篇 |
1995年 | 57篇 |
1994年 | 36篇 |
1993年 | 28篇 |
1992年 | 15篇 |
1991年 | 22篇 |
1990年 | 16篇 |
1989年 | 14篇 |
1988年 | 6篇 |
1987年 | 8篇 |
1986年 | 9篇 |
1985年 | 8篇 |
1984年 | 9篇 |
1983年 | 10篇 |
1982年 | 9篇 |
1981年 | 11篇 |
1980年 | 9篇 |
1979年 | 6篇 |
1976年 | 3篇 |
1975年 | 3篇 |
1974年 | 5篇 |
1970年 | 2篇 |
1957年 | 2篇 |
排序方式: 共有5666条查询结果,搜索用时 0 毫秒
111.
Pierre Deharo Nicolas Jaussaud Dominique Grisoli Olivier Camus Noemie Resseguier Herve Le Breton Vincent Auffret Jean Philippe Verhoye René Koning Thierry Lefevre Eric Van Belle Helene Eltchaninoff Martine Gilard Pascal Leprince Bernard Iung Marc Lambert Frédéric Collart Thomas Cuisset 《JACC: Cardiovascular Interventions》2018,11(19):1956-1965
Objectives
This study sought to describe the current practices and compare outcomes according to the use of balloon aortic valvuloplasty (BAV) or not during transcatheter aortic valve replacement (TAVR).Background
Since its development, aortic valve pre-dilatation has been an essential step of TAVR procedures. However, the feasibility of TAVR without systematic BAV has been described.Methods
TAVR performed in 48 centers across France between January 2013 and December 2015 were prospectively included in the FRANCE TAVI (Registry of Aortic Valve Bioprostheses Established by Catheter) registry. We compared outcomes according to BAV during the TAVR procedure.Results
A total of 5,784 patients have been included in our analysis, corresponding to 2,579 (44.6%) with BAV avoidance and 3,205 (55.4%) patients with BAV performed. We observed a progressive decline in the use of BAV over time (78% of procedures in 2013 and 49% in the last trimester of 2015). Avoidance of BAV was associated with similar device implantation success (97.3% vs. 97.6%; p = 0.40). TAVR procedures without BAV were quicker (fluoroscopy 17.2 ± 9.1 vs. 18.5 ± 8.8 min; p < 0.01) and used lower amounts of contrast (131.5 ± 61.6 vs. 141.6 ± 61.5; p < 0.01) and radiation (608.9 ± 576.3 vs. 667.0 ± 631.3; p < 0.01). The rates of moderate to severe aortic regurgitation were lower with avoidance of BAV (8.3% vs. 12.2%; p < 0.01) and tamponade rates (1.5% vs. 2.3%; p = 0.04).Conclusions
We confirmed that TAVR without BAV is frequently performed in France with good procedural results. This procedure is associated with procedural simplification and lower rates of residual aortic regurgitation. 相似文献112.
Anne-Esther Breyton Aurélie Goux Stéphanie Lambert-Porcheron Alexandra Meynier Monique Sothier Laurie VanDenBerghe Olivier Brack Emmanuel Disse Martine Laville Sophie Vinoy Julie-Anne Nazare 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2021,31(1):237-246
Background and aimsIn type 2 diabetes (T2D) patients, the reduction of glycemic variability and postprandial glucose excursions is essential to limit diabetes complications, beyond HbA1c level. This study aimed at determining whether increasing the content of Slowly Digestible Starch (SDS) in T2D patients’ diet could reduce postprandial hyperglycemia and glycemic variability compared with a conventional low-SDS diet.Methods and resultsFor this randomized cross-over pilot study, 8 subjects with T2D consumed a controlled diet for one week, containing starchy products high or low in SDS. Glycemic variability parameters were evaluated using a Continuous Glucose Monitoring System.Glycemic variability was significantly lower during High-SDS diet compared to Low-SDS diet for MAGE (Mean Amplitude of Glycemic Excursions, p < 0.01), SD (Standard Deviation, p < 0.05), and CV (Coefficient of Variation, p < 0.01). The TIR (Time In Range) [140–180 mg/dL[ was significantly higher during High-SDS diet (p < 0.0001) whereas TIRs ≥180 mg/dL were significantly lower during High-SDS diet. Post-meals tAUC (total Area Under the Curve) were significantly lower during High-SDS diet.ConclusionOne week of High-SDS Diet in T2D patients significantly improves glycemic variability and reduces postprandial glycemic excursions. Modulation of starch digestibility in the diet could be used as a simple nutritional tool in T2D patients to improve daily glycemic control.Registration numberin clinicaltrials.gov: NCT 03289494. 相似文献
113.
114.
115.
116.
117.
Marie Georgelin-Gurgel Franck Diemer Emmanuel Nicolas Martine Hennequin 《Journal of endodontics》2009,35(1):19-22
This observational study compared physiologic and psychological indicators of stress between two groups of 30 healthy patients undergoing either surgical or nonsurgical endodontic treatments. Heart rate (HR), systolic blood pressure (SBP), and diastolic blood pressure were monitored during care sessions. The patients were asked to score their anxiety before treatment and to report pain, stress, and/or discomfort experienced during care. Variations in HR and SBP were significantly dependent on treatment group (HR: F = 6, p < 0.001; SBP: F = 4, p = 0.05). Intergroup differences increased during the active steps of the treatment, such as local anesthesia, rotary instrumentation, periradicular curettage, root filling, and field removal. Moreover, the level of stress experienced during the care procedure was correlated to the level of anticipated anxiety in both groups. This study raises questions on the indications for anxiolysis or sedation in endodontic patients as a means of preventing the neurophysiologic consequences of stress. 相似文献
118.
Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. 总被引:7,自引:0,他引:7
Filip Baert Alain Schmit Geert D'Haens Franceska Dedeurwaerdere Edouard Louis Marc Cabooter Martine De Vos Fernand Fontaine Serge Naegels Piet Schurmans Hedwig Stals Karel Geboes Paul Rutgeerts 《Gastroenterology》2002,122(1):20-25
BACKGROUND & AIMS: Collagenous colitis (CC) is a well-described entity causing chronic diarrhea and characteristic histologic findings. Several treatment options have been suggested, but no controlled data are available. We conducted a placebo-controlled trial to show the clinical and histologic effects of budesonide in CC. METHODS: Twenty-eight patients were randomly assigned to receive placebo (n = 14) or budesonide 9 mg daily (n = 14) for 8 weeks. Patients were evaluated clinically, and blinded biopsy specimens were analyzed from fixed locations at weeks 0 and 8. Clinical response was defined as a decrease of at least 50% in the disease activity score (number of bowel movements in the last 7 days). At week 8, nonresponders received open-label budesonide for the next 8-week period; responders discontinued treatment and were followed up. RESULTS: Three patients discontinued the study prematurely. Intention-to-treat analysis showed clinical response in 8 of 14 patients in the budesonide group compared with 3 of 14 responders for placebo (P = 0.05) after 8 weeks of blinded therapy, together with improved stool consistency. Histologically, there was no change in the mean thickness of the collagen band but a significant decrease of the lamina propria infiltrate in the budesonide group (P < 0.001). CONCLUSIONS: Budesonide is efficacious in inducing short-term clinical response in CC with significant reduction of the histologic infiltrate in the lamina propria. 相似文献
119.
Laurent C Bourgeois A Faye MA Mougnutou R Seydi M Gueye M Liégeois F Kane CT Butel C Mbuagbaw J Zekeng L Mboup S Mpoudi-Ngolé E Peeters M Delaporte E 《The Journal of infectious diseases》2002,186(4):486-492
To compare human immunodeficiency virus (HIV) type 1 disease progression in patients infected by the predominant strain circulating recombinant form (CRF) 02_AG in western and west-central Africa and in patients infected by other strains, a prospective multicenter cohort study was conducted in Cameroon and Senegal. Among the 335 patients, a broad HIV-1 group M subtype diversity was observed in the envelope V3-V5 region, but strain CRF02_AG predominated in both Cameroon and Senegal (61.2% and 62.9%, respectively; P<.8). Multivariate analyses showed no difference between patients infected by CRF02 strains and those infected by other strains in terms of survival (adjusted hazards ratio [HR], 1.16; 95% confidence interval [CI], 0.76-1.78; P=.5), clinical disease progression (HR, 0.79; 95% CI, 0.50-1.25; P=.3), or square root CD4 cell decline (regression coefficient, -0.01; 95% CI, -0.82 to 0.81; P=.9). This study suggests that the predominance of HIV-1 CRF02_AG strain in western and west-central Africa should have no major clinical consequences. 相似文献